Position in MGNX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,163,305
+$3,598,620 QoQ
Shares Held
2,632,750
-11.2% QoQ
Ownership
4.13%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#4
of 122 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. MGNX ranks #45 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in MGNX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,163,305 | 2,632,750 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $8,564,685 | 2,963,559 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,682,895 | 2,908,631 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,858,054 | 1,701,223 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,605,057 | 1,326,494 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,463,382 | 1,152,270 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,750,199 | 538,523 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,047,611 | 318,423 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,057,114 | 484,027 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $10,525,197 | 715,027 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $7,345,129 | 763,527 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,099,599 | 665,150 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,038,303 | 754,823 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,121,480 | 574,823 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,241,755 | 483,123 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,761,911 | 509,223 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,221,222 | 1,430,923 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,160,122 | 585,712 | Shares | Sole | 2022-05-13 | |
| 2020-03-31 | $2,724,475 | 468,123 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||